Bluebird Bio

2 Beta Thalassemia Drugs Are Fast Approaching the Finish Line
2 Beta Thalassemia Drugs Are Fast Approaching the Finish Line
Motley Fool
Celgene
Bluebird Bio
beta thalassemia
LentiGlobin
luspatercept
Flag link:
Is bluebird bio One Step Closer to Its First Commercial Drug?
Is bluebird bio One Step Closer to Its First Commercial Drug?
Motley Fool
Bluebird Bio
beta thalassemia
LentiGlobin
Flag link:
Bluebird’s gene therapy for beta-thalassemia falls short of a cure, but still wows in 22 patients
Bluebird’s gene therapy for beta-thalassemia falls short of a cure, but still wows in 22 patients
Endpoints
Bluebird Bio
beta-thalassemia
gene therapy
Flag link:
Celgene, bluebird revise deal to co-develop CAR-T therapy
Celgene, bluebird revise deal to co-develop CAR-T therapy
Biopharma Dive
Celgene
Bluebird Bio
drug development
CAR-T
bb2121
Multiple Myeloma
Flag link:
bluebird bio Updates Plans for the Year Ahead
bluebird bio Updates Plans for the Year Ahead
Motley Fool
Bluebird Bio
earnings
Flag link:
How Celgene Hopes to Cash In on CAR-T
How Celgene Hopes to Cash In on CAR-T
Yahoo/Motley Fool
Celgene
CAR-T
JCAR017
bb2121
Bluebird Bio
Flag link:
As CAR-Ts go from candidates to brands, what's the marketing strategy?
As CAR-Ts go from candidates to brands, what's the marketing strategy?
Medical Marketing and Media
CAR-T
drug marketing
JCAR017
Juno Therapeutics
Celgene
bb2121
Bluebird Bio
apalutamide
Janssen
Flag link:
2 Biotech Acquisition Candidates That Could Be Next in M&A Crosshairs
2 Biotech Acquisition Candidates That Could Be Next in M&A Crosshairs
TheStreet.com
biotech
M&A
Bluebird Bio
Amicus Therapeutics
Flag link:
3 Small Biotechs That Big Drugmakers Are Probably Drooling Over
3 Small Biotechs That Big Drugmakers Are Probably Drooling Over
Motley Fool
biotech
Bluebird Bio
Madrigal Pharmaceuticals
SAGE Therapeutics
Flag link:
Bluebird Bio Shouldn’t Be Blue About Celgene’s Juno Deal
Bluebird Bio Shouldn’t Be Blue About Celgene’s Juno Deal
Washington Post, DC
Bluebird Bio
Celgene
Juno Therapeutics
M&A
CAR-T
Flag link:
5 Biotech Stocks That Could Be Bought Out in 2018
5 Biotech Stocks That Could Be Bought Out in 2018
Yahoo/Motley Fool
biotech stocks
Portola Pharmaceuticals
Tesaro
Bluebird Bio
Esperion Therapeutics
GlycoMimetics
Flag link:
JPM18: bluebird set to file 3 drugs for approval by 2019
JPM18: bluebird set to file 3 drugs for approval by 2019
Biopharma Dive
Bluebird Bio
JPMHC 2018
Lenti-D
gene therapy
LentiGlobin
bb2121
Flag link:
Celgene Shareholders Excited by CAR-T News
Celgene Shareholders Excited by CAR-T News
Motley Fool
Celgene
CAR-T
Bluebird Bio
bb2121
Flag link:
[video]ASH 2017 Recap: These Were the Big Winners and Losers
[video]ASH 2017 Recap: These Were the Big Winners and Losers
Motley Fool
ASH2017
Bluebird Bio
Juno Therapeutics
Spark Therapeutics
Biomarin
JNJ
Celgene
Flag link:
5 Biotech Buyout Candidates for 2018
5 Biotech Buyout Candidates for 2018
Yahoo/Motley Fool
biotech
M&A
Biogen
Biomarin
Bluebird Bio
Geron
SAGE Therapeutics
Flag link:
bluebird bio Stock Soars on Unprecedented Blood Cancer Study Results
bluebird bio Stock Soars on Unprecedented Blood Cancer Study Results
Motley Fool
Bluebird Bio
bb2121
CAR-T
Celgene
Multiple Myeloma
ASH17
Flag link:
A Virus Shortage? BlueBird Bio Buys A Factory To Make Its Own
A Virus Shortage? BlueBird Bio Buys A Factory To Make Its Own
Forbes
gene therapy
drug manufacturing
Bluebird Bio
Flag link:
9 Notable Biotechs Presenting At This Year's ASH Meeting
9 Notable Biotechs Presenting At This Year's ASH Meeting
Yahoo
ASH
Bluebird Bio
LentiGlobin
Ziopharm Oncology
Bellicum
BPX-501
Spark Therapeutics
SPK-8011
Biomarin
BMN 270
Juno Therapeutics
CAR-T
Novartis
Geron
imetelstat
Immunogen
IMGN632
IMGN779
Flag link:
Bluebird’s tweaked sickle cell gene therapy clears early test
Bluebird’s tweaked sickle cell gene therapy clears early test
Fierce Biotech
Bluebird Bio
sickle cell disease
gene therapy
HGB-206
Flag link:
Bluebird’s gene therapy halts progression of ‘devastating’ disease cALD
Bluebird’s gene therapy halts progression of ‘devastating’ disease cALD
Fierce Biotech
gene therapy
Bluebird Bio
cALD
Lenti-D
Flag link:

Pages